205 related articles for article (PubMed ID: 22419751)
1. Introducing parametric fusion PET/MRI of primary prostate cancer.
Park H; Wood D; Hussain H; Meyer CR; Shah RB; Johnson TD; Chenevert T; Piert M
J Nucl Med; 2012 Apr; 53(4):546-51. PubMed ID: 22419751
[TBL] [Abstract][Full Text] [Related]
2. Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.
Piert M; Park H; Khan A; Siddiqui J; Hussain H; Chenevert T; Wood D; Johnson T; Shah RB; Meyer C
J Nucl Med; 2009 Oct; 50(10):1585-93. PubMed ID: 19759109
[TBL] [Abstract][Full Text] [Related]
3. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
[TBL] [Abstract][Full Text] [Related]
4. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI,
Kitajima K; Yamamoto S; Kawanaka Y; Nakanishi Y; Yamada Y; Go S; Kanematsu A; Kaida H; Yamakado K
Hell J Nucl Med; 2020; 23(1):34-39. PubMed ID: 32222730
[TBL] [Abstract][Full Text] [Related]
6. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
Chang JH; Lim Joon D; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Tochon-Danguy H; Chan JG; Bolton D; Scott AM; Khoo V; Davis ID
Eur Radiol; 2014 Mar; 24(3):715-22. PubMed ID: 24192979
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions.
Chang JH; Lim Joon D; Davis ID; Lee ST; Hiew CY; Esler S; Gong SJ; Wada M; Clouston D; O'Sullivan R; Goh YP; Bolton D; Scott AM; Khoo V
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):438-45. PubMed ID: 25864171
[TBL] [Abstract][Full Text] [Related]
10. Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.
de Perrot T; Rager O; Scheffler M; Lord M; Pusztaszeri M; Iselin C; Ratib O; Vallee JP
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1744-55. PubMed ID: 24841413
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
12. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.
Garcia-Parra R; Wood D; Shah RB; Siddiqui J; Hussain H; Park H; Desmond T; Meyer C; Piert M
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1816-23. PubMed ID: 21833840
[TBL] [Abstract][Full Text] [Related]
13. Comparison of
Palard-Novello X; Beuzit L; Gambarota G; Le Jeune F; Garin E; Salaün PY; Devillers A; Querellou S; Bourguet P; Saint-Jalmes H
Ann Nucl Med; 2019 Jan; 33(1):47-54. PubMed ID: 30219990
[TBL] [Abstract][Full Text] [Related]
14. Combined PET/MRI improves diagnostic accuracy in patients with prostate cancer: a prospective diagnostic trial.
Hartenbach M; Hartenbach S; Bechtloff W; Danz B; Kraft K; Klemenz B; Sparwasser C; Hacker M
Clin Cancer Res; 2014 Jun; 20(12):3244-53. PubMed ID: 24763613
[TBL] [Abstract][Full Text] [Related]
15. Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [18F] choline PET/MRI.
Wetter A; Nensa F; Schenck M; Heusch P; Pöppel T; Bockisch A; Forsting M; Schlosser TW; Lauenstein TC; Nagarajah J
PLoS One; 2014; 9(7):e101571. PubMed ID: 25033396
[TBL] [Abstract][Full Text] [Related]
16. Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.
Beer AJ; Eiber M; Souvatzoglou M; Holzapfel K; Ganter C; Weirich G; Maurer T; Kübler H; Wester HJ; Gaa J; Krause BJ
Mol Imaging Biol; 2011 Apr; 13(2):352-61. PubMed ID: 20490932
[TBL] [Abstract][Full Text] [Related]
17. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
18. Imaging prostate cancer with 11C-choline PET/CT.
Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
[TBL] [Abstract][Full Text] [Related]
19. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
[TBL] [Abstract][Full Text] [Related]
20. Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques.
Park H; Meyer CR; Wood D; Khan A; Shah R; Hussain H; Siddiqui J; Seo J; Chenevert T; Piert M
Acad Radiol; 2010 May; 17(5):614-23. PubMed ID: 20188602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
